Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
MEDIUM RISK
Score updated Oct 13, 2026

MGNX — MacroGenics, Inc. Dilution Risk Tracker

Track MGNX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MGNX — Get alerts when the score changes →

As of October 13, 2026, MacroGenics, Inc. (MGNX) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. MacroGenics, Inc. has a market capitalization of $236.96M, 63.70M shares outstanding, 112 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
65
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (10mo)
🔔 Track MGNX — Get forecast alerts →

Market Data

Market Cap$236.96M
Shares Outstanding63.70M
Float55.60M
Cash$113.91M
Debt$36.51M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore43/100DilutionWatch score record
Shares Outstanding63.70MVerified float table or market cache
Public Float55.60MVerified float table or market cache
Market Cap$236.96MMarket data cache
Cash Runway9.7 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 20.2% shares (2026Q1 vs prior)
112 institutional holders · 49.16M shares
#1 ARMISTICE CAPITAL, LLC 6.01M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 5.31M shares
#3 RENAISSANCE TECHNOLOGIES LLC 2.96M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest7.04M
Days to Cover10.9
% of Float12.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2016-02-29
4 INSIDER TRANSACTION 2026-02-17
4 INSIDER TRANSACTION 2026-02-17
4 INSIDER TRANSACTION 2026-02-17
4 INSIDER TRANSACTION 2026-02-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual MGNX Dilution Snapshot

MacroGenics, Inc. (MGNX) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

MGNX's DilutionScore is currently 43/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 50/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202643/100MEDIUM53 days
Jul 16 – Aug 21, 202650/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

MGNX shares outstanding have increased 0.5% from 63.26M (Mar 2026) to 63.56M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 15, 202663.56M55.60M▲ 0.01%
Mar 14, 202663.26M55.59M▲ 0.07%
Mar 11, 202663.26M55.55M▲ 0.47%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track MGNX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment MGNX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking MGNX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MGNX
MGNX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.